Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Izawa · SciRah

Researcher profile · Semantic Scholar

N. Izawa

Share profile

N. Izawa — researcher profile on SciRah

h-index: 11
Works: 108
Citations: 556

Most-cited papers

Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer
T. Nakajima, S. Kadowaki, K. Minashi, T. Nishina +7 more
2020Clinical Cancer Research57 citations
Semantic Scholar
Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives
T. Mizukami, N. Izawa, T. Nakajima, Y. Sunakawa
2019Drugs49 citations
Semantic Scholar
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
Toshio Shimizu, T. Nakajima, N. Yamamoto, K. Yonemori +10 more
2022Investigational new drugs37 citations
Semantic Scholar
The molecular landscape of pancreatobiliary cancers for novel targeted therapies from real-world genomic profiling.
K. Umemoto, Hiroyuki Yamamoto, R. Oikawa, Hiroyuki Takeda +9 more
2022Journal of the National Cancer Institute27 citations Open access
Semantic Scholar
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
T. Tsuda, C. Kyomori, T. Mizukami, T. Taniyama +7 more
2016Molecular and clinical oncology19 citations Open access
Semantic Scholar
The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study
N. Izawa, H. Shiokawa, R. Onuki, K. Hamaji +7 more
2022ESMO Open17 citations Open access
Semantic Scholar
FMS‐like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer
H. Hasegawa, H. Taniguchi, Yoshiaki Nakamura, Takeshi Kato +22 more
2020Cancer Science17 citations Open access
Semantic Scholar
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial
N. Izawa, T. Masuishi, N. Takahashi, H. Shoji +19 more
2023Targeted oncology12 citations
Semantic Scholar
Identification of a FGFR3-TACC3 fusion in esophageal cancer.
T. Mizukami, K. Sakai, S. Naruki, T. Taniyama +9 more
2016Annals of Oncology12 citations Open access
Semantic Scholar
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)
K. Ando, Yoshiaki Nakamura, H. Kitao, M. Shimokawa +24 more
2023British Journal of Cancer11 citations Open access
Semantic Scholar
Early morphological change for predicting outcome in metastatic colorectal cancer after regorafenib
H. Arai, K. Miyakawa, T. Denda, T. Mizukami +7 more
2017OncoTarget11 citations Open access
Semantic Scholar
Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer
A. Doi, T. Mizukami, Hiroyuki Takeda, K. Umemoto +5 more
2023Frontiers in Oncology10 citations Open access
Semantic Scholar
Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size
K. Sakamaki, Y. Kito, K. Yamazaki, N. Izawa +3 more
2017ESMO Open10 citations Open access
Semantic Scholar
Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study
Y. Narita, T. Matsushima, Y. Sakamoto, H. Matsuoka +11 more
2023ESMO Open9 citations Open access
Semantic Scholar
The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced pancreatic cancer.
N. Izawa, C. Morizane, H. Takahashi, M. Ueno +16 more
2018Annals of Oncology9 citations Open access
Semantic Scholar
TRIDENTE trial: A phase II study of rechallenge with encorafenib, binimetinib, and cetuximab in patients with RAS wild-type/BRAF V600E–mutant metastatic colorectal cancer.
D. Kotani, Y. Kagawa, Y. Matsubara, H. Bando +11 more
2023Journal of Clinical Oncology8 citations Open access
Semantic Scholar
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment
T. Mizukami, K. Hamaji, R. Onuki, Ayako Yokomizo +15 more
2021Nutrition and Cancer8 citations
Semantic Scholar
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.
D. Kotani, A. Takashima, T. Kato, T. Satoh +15 more
2024Clinical colorectal cancer7 citations Open access
Semantic Scholar
Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients
Mitsuhiko Ota, H. Saeki, Hideo Uehara, Yoshiko Matsuda +13 more
2023International Journal of Clinical Oncology7 citations Open access
Semantic Scholar
O14-1 A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G
A. Makiyama, H. Shoji, H. Kawakami, Takao Tamura +15 more
2023Annals of Oncology7 citations Open access
Semantic Scholar
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
N. Izawa, K. Shitara, K. Yonesaka, T. Yamanaka +16 more
2020Targeted oncology7 citations
Semantic Scholar
A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701.
Kazuma Kobayshi, Koichi Suyama, H. Katsuya, N. Izawa +14 more
2022European Journal of Cancer6 citations Open access
Semantic Scholar
LBA63 Placebo-controlled, double-blinded phase Ⅲ study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial
K. Shimomura, H. Minatogawa, T. Mashiko, H. Arioka +16 more
2021Annals of Oncology6 citations Open access
Semantic Scholar
Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy
H. Minatogawa, N. Izawa, T. Kawaguchi, T. Miyaji +16 more
2020BMJ Open6 citations Open access
Semantic Scholar
Antibiotics may enhance the efficacy of gemcitabine treatment for advanced pancreatic cancer.
Y. Sunakawa, Hiroyuki Arai, N. Izawa, T. Mizukami +6 more
2018Annals of Oncology6 citations Open access
Semantic Scholar
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy
Y. Sunakawa, N. Izawa, T. Mizukami, Y. Horie +5 more
2017OncoTargets and Therapy6 citations Open access
Semantic Scholar
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)
R. Kawabata, N. Izawa, Takahisa Suzuki, Y. Nagahisa +17 more
2023Targeted oncology5 citations
Semantic Scholar
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers
Hiroyuki Takeda, K. Imoto, K. Umemoto, A. Doi +9 more
2022Targeted oncology5 citations
Semantic Scholar
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
S. Yamamoto, K. Nagashima, T. Kawakami, S. Mitani +13 more
2021BMC Cancer5 citations Open access
Semantic Scholar
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer
Y. Kito, H. Satake, H. Taniguchi, Takeshi Yamada +9 more
2020Cancer Chemotherapy and Pharmacology5 citations
Semantic Scholar
A phase I/II study of nivolumab, paclitaxel, and ramucirumab as second-line in advanced gastric cancer.
S. Hironaka, S. Kadowaki, N. Izawa, T. Nishina +8 more
20205 citations
Semantic Scholar
Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report
A. Doi, Hiroyuki Takeda, K. Umemoto, Ryosuke Oumi +10 more
2020World Journal of Gastrointestinal Oncology5 citations Open access
Semantic Scholar
Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy
T. Taniyama, T. Tsuda, K. Miyakawa, H. Arai +8 more
2019Esophagus5 citations
Semantic Scholar
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
Hiroyuki Arai, Yan Yang, Y. Baca, J. Millstein +28 more
2024European Journal of Cancer4 citations Open access
Semantic Scholar
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study
M. Nakamura, A. Ishiguro, M. Dazai, Y. Kawamoto +15 more
2022BMC Cancer3 citations Open access
Semantic Scholar
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)
W. Okamoto, K. Sakai, A. Makiyama, Y. Yamamoto +15 more
2022ESMO Open3 citations Open access
Semantic Scholar
Vascular endothelial growth factor (VEGF)-D and clinical outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with second-line FOLFIRI plus bevacizumab (Bev): A biomarker study of the WJOG 6210G trial.
N. Izawa, K. Shitara, T. Masuishi, T. Denda +16 more
20203 citations
Semantic Scholar
The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced esophageal cancer.
K. Kato, T. Kojima, H. Saeki, H. Hara +16 more
2018Annals of Oncology3 citations Open access
Semantic Scholar
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.
Y. Horie, K. Yamazaki, T. Funakoshi, S. Hamauchi +14 more
2015Molecular and clinical oncology3 citations Open access
Semantic Scholar
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
S. Mitani, Y. Kito, K. Hino, K. Kawakami +12 more
2023Targeted oncology2 citations
Semantic Scholar
Safety and efficacy of encorafenib, binimetinib, plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer: Results of a prospective study as an expanded access program.
A. Takashima, D. Kotani, T. Kato, T. Satoh +12 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
Detection of a pinhole‐sized bronchoesophageal fistula under bronchoscopic autofluorescence imaging
K. Morikawa, N. Izawa, H. Kida, H. Handa +2 more
2021Thoracic Cancer2 citations Open access
Semantic Scholar
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
K. Umemoto, Hiroyuki Yamamoto, R. Oikawa, Hiroyuki Takeda +8 more
20212 citations
Semantic Scholar
Microsatellite instability status in metastatic colorectal cancer and effect of immune checkpoint inhibitors on survival in MSI-high metastatic colorectal cancer
W. Okamoto, Yusuke Nakamura, M. Shiozawa, Y. Komatsu +16 more
2019Annals of Oncology2 citations Open access
Semantic Scholar
Association of gastric acid suppression with efficacy of immune checkpoint inhibitors (ICIs) in advanced cancer patients
N. Izawa, H. Shiokawa, R. Onuki, K. Hamaji +13 more
2019Annals of Oncology2 citations Open access
Semantic Scholar
A retrospective observational study to evaluate the efficacy of trifluridine/tipiracil ± bevacizumab in metastatic colorectal cancer with MSI-high/deficient MMR.
R. Inamoto, Hiroko Hasegawa, K. Sugiyama, N. Izawa +7 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Phase 1b study of futibatinib plus pembrolizumab with or without chemotherapy in patients with esophageal carcinoma: Updated results of antitumor activity.
A. Ooki, K. Muro, K. Nishino, H. Kawakami +13 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
A multicenter single-arm phase II study examining the efficacy of TNT for locally advanced rectal cancer: ENSEMBLE-2.
K. Ando, Y. Kagawa, Mamoru Uemura, J. Watanabe +15 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
P-23 Clinical outcomes of encorafenib, binimetinib, and cetuximab for pretreated BRAF V600E-mutant metastatic colorectal cancer in the BEACON EAP follow-up study
T. Kato, D. Kotani, A. Takashima, T. Satoh +13 more
2023Annals of Oncology1 citations Open access
Semantic Scholar
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study
D. Takahari, H. Katai, A. Takashima, N. Izawa +17 more
2023Gastric Cancer1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Y. Sunakawa×21
Invite
Y. Sunakawa — researcher profile on SciRah
Y. Horie×18
Invite
Y. Horie — researcher profile on SciRah
T. Nakajima×17
Invite
T. Nakajima — researcher profile on SciRah
T. Mizukami×16
Invite
T. Mizukami — researcher profile on SciRah

×12

Invite

T. Esaki — researcher profile on SciRah

Invite

A. Doi — researcher profile on SciRah

Invite

T. Ogura — researcher profile on SciRah

Invite

T. Tsuda — researcher profile on SciRah

T. Masuishi×11

Invite

T. Masuishi — researcher profile on SciRah

K. Yamazaki×10

Invite

K. Yamazaki — researcher profile on SciRah

Invite

H. Arai — researcher profile on SciRah

Invite

T. Yoshino — researcher profile on SciRah